<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00330824</url>
  </required_header>
  <id_info>
    <org_study_id>BRA-05-02</org_study_id>
    <nct_id>NCT00330824</nct_id>
  </id_info>
  <brief_title>Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Post Operative Inflammation in LASIK Surgery</brief_title>
  <official_title>Efficacy of Antibiotic Steroid Combination Compared With Individual Administration in Prevention of Post Operative Inflammation in Patients Having LASIK Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Efficacy/Safety of antibiotic steroid combination compared with individual administration in
      inflammation Post-LASIK
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      antibiotic/steroid combination compared to individuals components 15 days of treatment
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <primary_completion_date type="Actual">September 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>day 15 evaluation of anterior chamber</measure>
    <time_frame>15 days pos-op</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>day 15 evaluation of ocular pain, physician´s follow-up impression of inflammatory reaction score</measure>
    <time_frame>15 days pos-op</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Post Lasik Surgery Inflammation</condition>
  <arm_group>
    <arm_group_label>antibiotic steroid (single vial)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>efficacy of antibiotic steroid combination compared with individual administration in prevention of postoperative inflammation in patients having LASIK surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>antibiotic / steroid (2 vials)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>efficacy of antibiotic steroid combination compared with individual administration in prevention of postoperative inflammation in patients having LASIK surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>antibiotic/steroid combination</intervention_name>
    <description>1gtt, 4x/d, 15 days</description>
    <arm_group_label>antibiotic steroid (single vial)</arm_group_label>
    <other_name>moxifloxacin/dexamethasone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>moxifloxacin/dexamethasone</intervention_name>
    <description>1gtt, 4x/days, 15 days</description>
    <arm_group_label>antibiotic / steroid (2 vials)</arm_group_label>
    <other_name>moxifloxacin / dexamethasone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients having LASIK surgery;

          -  men or women of any race, between 18 and 50 years old, presenting up to 8 degrees of
             myopia or up to 4 degrees of hypermetropia, or up to 3 degrees of astigmatism, without
             any other associated ocular problems

        Exclusion Criteria:

          -  Uncontrolled glaucoma or intraocular hypertension;

          -  Use of any ocular anti-infectious drugs or any topical or systemic ocular NSAIDs
             during the study but study drugs;

          -  A history of chronic or recurrent ocular inflammatory disease;

          -  Uncontrolled diabetes mellitus and diabetic retinopathy ;

          -  Patients with sight in a single eye;

          -  Iris atrophy in the eye to be operated;

          -  Pregnant or lactating women, or women of childbearing potential who are not using
             proper birth-control methods;

          -  Known or suspected allergy or hypersensitivity to any component of study medication;

          -  A history or any other evidence of severe systemic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rubens Belfort Jr, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Ophthalmology - Rua Botucatu 824</name>
      <address>
        <city>São paulo</city>
        <state>SP</state>
        <zip>04023-062</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2006</study_first_submitted>
  <study_first_submitted_qc>May 26, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2006</study_first_posted>
  <last_update_submitted>August 6, 2009</last_update_submitted>
  <last_update_submitted_qc>August 6, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2009</last_update_posted>
  <responsible_party>
    <name_title>Rubens Belfort Jr</name_title>
    <organization>Head Professor of Ophthalmology</organization>
  </responsible_party>
  <keyword>prevention of post inflammation in LASIK surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Moxifloxacin</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Fluoroquinolones</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

